ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Trade (domestic/foreign) TRD

Free Trade Agreements-Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines

Contacted: Congressional Budget Office (CBO); Federal Trade Commission (FTC); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); White House Office; Patent & Trademark Office (PTO); SENATE; Medicare Payment Advisory Commission (MedPAC); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic Drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R. 3497 - MODDERN Cures Act of 2011 H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R. 4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S. 27 Preserve Access to Affordable Generics Act S. 373 Fair Prescription Drug Competition Act S. 1734 - Generating Antibiotic Incentives Now Act of 2011 S. 1882 - The Fair and Immediate Release of Generic Drugs Act S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act

Contacted: U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); SENATE; Congressional Budget Office (CBO); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Commerce, Dept of (DOC); White House Office; Food & Drug Administration (FDA)

Bills named: S. 1734 (112th), S. 373 (112th), S. 27 (112th), H.R. 3497 (112th), S. 1882 (112th), S. 3187 (112th), H.R. 3995 (112th), H.R. 2182 (112th), S. 2516 (112th), H.R. 5651 (112th), H.R. 3988 (112th), H.R. 4332 (112th)

Medicare/Medicaid MMM

FY 2014 Budget, FY 2013 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and generic drugs H.R. 3342 - Affordable Medicines Utilization Act of 2011 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R.6160 - Stop Tampering of Prescription Pills Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 S. 44 Medicare Prescription Drug Negotiation Act S. 1356 - Affordable Medicines Utilization Act of 2011 S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act S.1855 - Pandemic and All-Hazards Preparedness Act Reauthorization of 2011

Contacted: Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); White House Office; Commerce, Dept of (DOC); Food & Drug Administration (FDA); SENATE

Bills named: S. 1356 (112th), S. 1855 (112th), S. 2516 (112th), H.R. 5651 (112th), H.R. 6433 (112th), S. 3187 (112th), H.R. 6160 (112th), H.R. 3342 (112th), S. 44 (112th)

Budget/Appropriations BUD

FY 2014 Budget, FY 2013 Budget, Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY12 and FY13 Budget H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 H.J.RES.117 - Continuing Appropriations Resolution, 2013 H.RES.778 - Providing for consideration of the joint resolution (H.J. Res. 117) making continuing appropriations for fiscal year 2013 S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act

Contacted: Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Congressional Budget Office (CBO); SENATE; White House Office; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Federal Trade Commission (FTC); Food & Drug Administration (FDA)

Bills named: S. 3187 (112th), H.J.Res. 117 (112th), H.R. 6433 (112th), H.Res. 778 (112th), S. 2516 (112th), H.R. 5651 (112th), H.R. 3988 (112th)

Pharmacy PHA

FY 2014 Budget, FY 2013 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, prescription drug abuse and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R. 3026 - Safeguarding America's Pharmaceuticals Act of 2011 H.R. 3839 - Drug Shortage Prevention Act of 2012 H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R. 4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R.6160 - Stop Tampering of Prescription Pills Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 H.R.6584 - Verifying Authority and Legality In Drug Compounding Act of 2012 H.R.6611 - Patient Access to Drugs in Shortage Act of 2012 H.R.6638 - S.A.F.E. Compounded Drugs Act of 2012 S. 44 Medicare Prescription Drug Negotiation Act S. 296 and H.R.2245 Preserving Access to Life-Saving Medication Act S. 373 Fair Prescription Drug Competition Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1734 - Generating Antibiotic Incentives Now Act of 2011 S. 2295 - Patient Safety and Generic Labeling Improvement Act S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act S.1855 - Pandemic and All-Hazards Preparedness Act Reauthorization of 2011

Contacted: Medicare Payment Advisory Commission (MedPAC); U.S. Trade Representative (USTR); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); White House Office; Federal Trade Commission (FTC); Office of Management & Budget (OMB); Congressional Budget Office (CBO)

Bills named: S. 2295 (112th), H.R. 6160 (112th), H.R. 2182 (112th), S. 296 (112th), S. 2516 (112th), H.R. 6433 (112th), S. 1584 (112th), H.R. 4332 (112th), H.R. 6584 (112th), S. 3187 (112th), H.R. 2245 (112th), H.R. 5651 (112th), H.R. 3995 (112th), S. 373 (112th), S. 1734 (112th), S. 44 (112th), H.R. 3839 (112th), H.R. 3988 (112th), S. 1855 (112th), H.R. 3026 (112th), H.R. 6638 (112th), H.R. 6611 (112th)